Calidi Biotherapeutics annual current ratio
2021
2022
2023
2024
2025
Calidi Biotherapeutics Current Ratio Growth & History (CLDI)
Calidi Biotherapeutics's current ratio was 1.59 for fiscal 2025.
View full Calidi Biotherapeutics company overviewCalidi Biotherapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.59 | 0.51 | +47.62% |
| 2024 | 2024-12-31 | 1.08 | 0.66 | +156.09% |
| 2023 | 2023-12-31 | 0.42 | 0.40 | +2200.09% |
| 2022 | 2022-12-31 | 0.02 | −3.59 | −99.49% |
| 2021 | 2021-12-31 | 3.61 | — | — |
Calidi Biotherapeutics quarterly current ratio
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.68 | 0.55 | +48.39% |
| Q1 2026 | 2026-03-31 | 1.92 | −0.20 | −9.47% |
| Q4 2025 | 2025-12-31 | 1.59 | 0.51 | +47.62% |
| Q3 2025 | 2025-09-30 | 2.12 | 1.93 | +1007.14% |
| Q2 2025 | 2025-06-30 | 1.13 | 1.01 | +807.63% |
| Q1 2025 | 2025-03-31 | 2.12 | 1.99 | +1535.41% |
| Q4 2024 | 2024-12-31 | 1.08 | 0.66 | +156.09% |
| Q3 2024 | 2024-09-30 | 0.19 | −0.88 | −82.15% |
| Q2 2024 | 2024-06-30 | 0.12 | 0.03 | +28.07% |
| Q1 2024 | 2024-03-31 | 0.13 | 0.09 | +218.57% |
| Q4 2023 | 2023-12-31 | 0.42 | 0.40 | +2200.09% |
| Q3 2023 | 2023-09-30 | 1.07 | 0.72 | +200.55% |
| Q2 2023 | 2023-06-30 | 0.10 | −1.94 | −95.22% |
| Q1 2023 | 2023-03-31 | 0.04 | −2.63 | −98.48% |
| Q4 2022 | 2022-12-31 | 0.02 | −3.59 | −99.49% |
| Q3 2022 | 2022-09-30 | 0.36 | −41.50 | −99.15% |
| Q2 2022 | 2022-06-30 | 2.03 | — | — |
| Q1 2022 | 2022-03-31 | 2.67 | — | — |
| Q4 2021 | 2021-12-31 | 3.61 | — | — |
| Q3 2021 | 2021-09-30 | 41.86 | — | — |
Calidi Biotherapeutics current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Calidi Biotherapeutics's current ratio decreased from 3.61 to 1.59, a change of −2.02. The latest reported quarter, Q2 2026, shows 1.68.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Calidi Biotherapeutics source filings ↗